Dr. Jennifer Shuford, the head of Texas’ public health agency, has been appointed to serve as the chief medical officer at the Centers for Disease Control and Prevention (CDC). This significant announcement was made by President Donald Trump, who highlighted Shuford’s expertise among a slate of proposed leaders for the federal agency in a post on Truth Social.
In addition to Shuford, Trump’s executive appointments include Dr. Erica Schwartz as CDC director, Sean Slovenski as deputy director and chief operating officer, and Dr. Sara Brenner as senior counselor for public health to U.S. Health Secretary Robert F. Kennedy, Jr. Notably, while Schwartz’s nomination requires Senate approval, Shuford’s position does not necessitate such a process.
Trump expressed confidence in his nominees, stating that their collective “knowledge, experience, and TOP degrees” would aim to “restore the GOLD STANDARD OF SCIENCE at the CDC.” This comes at a time when the agency has faced criticism and departures from key leaders due to shifts in public health practices, particularly concerning vaccination protocols.
Public health experts have shown optimism about the future of the CDC following these appointments. Shuford, in particular, is seen as a promising choice due to her scientific background and absence of connections to anti-vaccine movements. Before her current role, she was an infectious disease physician in Austin and joined the Texas Department of State Health Services (DSHS) in 2017.
As the commissioner of DSHS, Shuford played a critical role in Texas’s response to the COVID-19 pandemic and was instrumental during the West Texas measles outbreak in 2022, which marked the largest outbreak in the U.S. in three decades, infecting 762 individuals and resulting in two fatalities. Her leadership during this crisis included overseeing significant financial investments to promote vaccination and awareness within communities.
During the measles outbreak, Shuford emphasized the effectiveness of the measles vaccine, stating, “That vaccine is highly effective and was the reason why measles was eliminated from the United States in the year 2000.” Her firm stance on vaccination contrasts sharply with the evolving views of Kennedy regarding immunizations.
Joseph Kanter, CEO of the Association of State and Territorial Health Officials, expressed support for Shuford’s appointment. He noted her respect within public health and governmental circles and commended her commitment to evidence-based practices.
The previous chief medical officer, Debra Houry, departed from the CDC in August, citing concerns over an “erosion of our science and the data and a lack of trust in it.” Houry, along with other leaders, left due to disagreements with the agency’s direction under Kennedy’s leadership. In a December essay, she criticized the shift away from trusted scientific voices and warned of predictable outcomes stemming from such changes.
As the CDC prepares for this new leadership, the appointment of Shuford and her colleagues may signal a renewed focus on scientific integrity and public trust in health initiatives.
Disclosure: The Texas Medical Association has been a financial supporter of The Texas Tribune, a nonprofit, nonpartisan news organization. Financial supporters play no role in the Tribune’s journalism. For a complete list of supporters, please visit their website.
